- Home
- FTFT vs ALLR Comparison
FTFT vs ALLR Comparison
Compare FTFT & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ALLR
- Stock Information
- Founded
- FTFT N/A
- ALLR 2004
- Country
- FTFT United States
- ALLR United States
- Employees
- FTFT N/A
- ALLR N/A
- Industry
- FTFT Business Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- ALLR Health Care
- Exchange
- FTFT Nasdaq
- ALLR Nasdaq
- Market Cap
- FTFT 19.7M
- ALLR 15.8M
- IPO Year
- FTFT N/A
- ALLR N/A
- Fundamental
- Price
- FTFT $2.50
- ALLR $1.02
- Analyst Decision
- FTFT
- ALLR
- Analyst Count
- FTFT 0
- ALLR 0
- Target Price
- FTFT N/A
- ALLR N/A
- AVG Volume (30 Days)
- FTFT 5.2M
- ALLR 440.9K
- Earning Date
- FTFT 08-18-2025
- ALLR 08-04-2025
- Dividend Yield
- FTFT N/A
- ALLR N/A
- EPS Growth
- FTFT N/A
- ALLR N/A
- EPS
- FTFT N/A
- ALLR N/A
- Revenue
- FTFT $2,031,913.00
- ALLR N/A
- Revenue This Year
- FTFT N/A
- ALLR N/A
- Revenue Next Year
- FTFT N/A
- ALLR N/A
- P/E Ratio
- FTFT N/A
- ALLR N/A
- Revenue Growth
- FTFT N/A
- ALLR N/A
- 52 Week Low
- FTFT $1.01
- ALLR $0.61
- 52 Week High
- FTFT $5.70
- ALLR $7.38
- Technical
- Relative Strength Index (RSI)
- FTFT 57.54
- ALLR 51.84
- Support Level
- FTFT $2.35
- ALLR $0.95
- Resistance Level
- FTFT $2.98
- ALLR $1.14
- Average True Range (ATR)
- FTFT 0.49
- ALLR 0.07
- MACD
- FTFT 0.03
- ALLR -0.00
- Stochastic Oscillator
- FTFT 44.36
- ALLR 38.46
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.